JBS Science Inc.

Lansdale, PA

UEI
DG7YFQJF7UJ5
CAGE
6B1J0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
210 W Main St, Lansdale, PA 19446, USA
Website
jbs-science.com
Founded
2011
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Cell-free circulating DBA-based assay development for liver cancer screening HHSN261201600058C National Cancer Institute (NIH) $273,600

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

JBS Science Inc. is a corporate entity registered to receive federal grant awards. Based on the award descriptions, it appears to be a biotechnology or life sciences company focused on developing molecular diagnostic tests and assays, particularly in the areas of cancer and infectious diseases.

JBS Science Inc. has received several federal grant awards from the National Institutes of Health (NIH) for the development of novel diagnostic tests and assays. One award aims to create a urine-based liquid biopsy assay for comprehensive genetic characterization of non-muscle-invasive bladder cancer (NMIBC), to guide treatment and monitor recurrence. This involves developing a bladder cancer-targeted, hybridization-based next-generation sequencing (NGS) assay and data analysis pipeline, as well as comparing tissue/urine and tissue/plasma variant concordances. Another award is for the development of a quantitative PCR assay for detecting hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the blood, which is crucial for monitoring the effectiveness of antiviral therapies and facilitating drug development. The third award focuses on creating a non-invasive urine test to detect and characterize integrated HBV DNA, which can be used to monitor antiviral treatment efficacy and identify patients who have achieved a functional cure. This involves improving a prototype HBV-host junction detection assay and developing a computational pipeline for comprehensive profiling of HBV integration and genetics. The awards involve collaborations with academic medical centers and research institutes for sample collection and clinical validation.

Quick answers

Is JBS Science Inc. registered in SAM.gov?

Yes. JBS Science Inc.'s SAM.gov registration is active through October 8, 2027.

What is JBS Science Inc.'s CAGE code?

JBS Science Inc.'s CAGE code is 6B1J0, and its Unique Entity ID (UEI) is DG7YFQJF7UJ5.

What is JBS Science Inc.'s most recent federal award?

JBS Science Inc.'s most recent federal grant award is Development of a urine genetic test for non-muscle-invasive bladder cancer there is an urgent unmet need for a test… (R43HG013476), from National Human Genome Research Institute (NIH), on August 1, 2023.

On GovTribe

See JBS Science Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe